37351564 37351564 Wharton S, Blevins T, Connery L et al (2023) Daily Oral GLP‐1 Receptor Agonist Orforglipron for Adults with Obesity. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.